Evidence map›Paper›PMID 31919357›Full record

ArticleNature communications2020

The inducible amphisome isolates viral hemagglutinin and defends against influenza A virus infection.

Jumpei Omi, Miho Watanabe-Takahashi, Katsura Igai, Eiko Shimizu, Ching-Yi Tseng, Tomohiro Miyasaka, Tsuyoshi Waku, Shinichiro Hama, Rieka Nakanishi, Yuki Goto and 5 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Antiviral Peptides as Anti-Influenza Agents.International journal of molecular sciences · 2022
    Review
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 1 country.

Jumpei OmiDepartment of Molecular Life Sciences, Graduate School of Life and Medical Sciences, Doshisha University, Kyoto, 6100394, Japan.ORCID http://orcid.org/0000-0003-2503-6045
Miho Watanabe-TakahashiDepartment of Molecular Life Sciences, Graduate School of Life and Medical Sciences, Doshisha University, Kyoto, 6100394, Japan.
Katsura IgaiDepartment of International Health, Institute of Tropical Medicine, Nagasaki University, Nagasaki, 8528523, Japan.
Eiko ShimizuDepartment of Molecular Life Sciences, Graduate School of Life and Medical Sciences, Doshisha University, Kyoto, 6100394, Japan.
Ching-Yi TsengDepartment of Molecular Life Sciences, Graduate School of Life and Medical Sciences, Doshisha University, Kyoto, 6100394, Japan.
Tomohiro MiyasakaDepartment of Neuropathology, Graduate School of Life and Medical Sciences, Doshisha University, Kyoto, 6100394, Japan.
Tsuyoshi WakuDepartment of Genetic Code, Graduate School of Life and Medical Sciences, Doshisha University, Kyoto, 6100394, Japan.
Shinichiro HamaDepartment of Molecular Life Sciences, Graduate School of Life and Medical Sciences, Doshisha University, Kyoto, 6100394, Japan.
Rieka NakanishiDepartment of Molecular Life Sciences, Graduate School of Life and Medical Sciences, Doshisha University, Kyoto, 6100394, Japan.
Yuki GotoDepartment of Molecular Life Sciences, Graduate School of Life and Medical Sciences, Doshisha University, Kyoto, 6100394, Japan.
Yuri NishinoGraduate School of Life Science, University of Hyogo, Hyogo, 6781297, Japan.
Atsuo MiyazawaGraduate School of Life Science, University of Hyogo, Hyogo, 6781297, Japan.
Yasuhiro NatoriDepartment of Health Chemistry, School of Pharmacy, Iwate Medical University, Iwate, 0208505, Japan.
Makoto YamashitaDepartment of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo, 1088639, Japan.
Kiyotaka NishikawaDepartment of Molecular Life Sciences, Graduate School of Life and Medical Sciences, Doshisha University, Kyoto, 6100394, Japan. knishika@mail.doshisha.ac.jp.
Doshisha University · JPUniversity of Hyogo · JPIwate Medical University · JPNagasaki International University · JPTokyo University of Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The emergence of drug-resistant influenza type A viruses (IAVs) necessitates the development of novel anti-IAV agents. Here, we target the IAV hemagglutinin (HA) protein using multivalent peptide library screens and identify PVF-tet, a peptide-based HA inhibitor. PVF-tet inhibits IAV cytopathicity and propagation in cells by binding to newly synthesized HA, rather than to the HA of the parental virus, thus inducing the accumulation of HA within a unique structure, the inducible amphisome, whose production from the autophagosome is accelerated by PVF-tet. The amphisome is also produced in response to IAV infection in the absence of PVF-tet by cells overexpressing ABC transporter subfamily A3, which plays an essential role in the maturation of multivesicular endosomes into the lamellar body, a lipid-sorting organelle. Our results show that the inducible amphisomes can function as a type of organelle-based anti-viral machinery by sequestering HA. PVF-tet efficiently rescues mice from the lethality of IAV infection.

Indexed as

AnimalsAntiviral AgentsATP-Binding Cassette TransportersAutophagosomesDogsDrug Evaluation, PreclinicalEndosomesFemaleHemagglutinins, ViralInfluenza A virusMadin Darby Canine Kidney CellsMiceMice, Inbred BALB COrthomyxoviridae InfectionsPeptide LibraryPeptidesAbca3 protein, mouseAntiviral AgentsATP-Binding Cassette TransportersHemagglutinins, ViralPeptide LibraryPeptides

Identifiers

PMID31919357
PMCPMC6952414
OpenAlexW2998994120

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.